-transparent.png){kind=logo}
Kynurenic acid, a tryptophan metabolite able to antagonize the actions of the excitatory amino acids, has been identified and measured for the first time in the brain of mice, rats, guinea pigs, and humans by using an HPLC method. Its content was 5.8 +/- 0.9 in mouse brain, 17.8 +/- 2.0 in rat brain, 16.2 +/- 1.5 in guinea pig brain, 26.8 +/- 2.9 in rabbit brain, and 150 +/- 30 in human cortex (pmol/g wet wt. mean +/- SE). The regional distribution of this molecule was uneven. In rats, guinea pigs, and rabbits, the brainstem was the area richest in this compound. Tryptophan administration (100-300 mg/kg, i.p.) to rats resulted in a significant increase of the brain content of kynurenic acid. Similarly, 1 h after probenecid administration (200 mg/kg, i.p.), the brain content of kynurenate increased by fourfold, thus suggesting that its turnover rate is relatively fast.
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
January 1991,
Advances in experimental medicine and biology,
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
February 1986,
Proceedings of the National Academy of Sciences of the United States of America,
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
January 2009,
Amino acids,
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
February 2015,
Journal of animal physiology and animal nutrition,
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
December 2001,
Neuroreport,
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
July 1992,
Brain research. Developmental brain research,
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
August 2001,
Life sciences,
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
January 1998,
Amino acids,
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
January 1998,
Developmental neuroscience,
F Moroni, and
P Russi, and
G Lombardi, and
M Beni, and
V Carlà
July 1997,
Journal of neurochemistry,
